Abstract
Development and Scale-Up of an Enabling Synthetic Route to <b>KTX-005</b>, a Muscarinic Acetylcholine Receptor Agonist for the Potential Treatment of Schizophrenia
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have